Efficacy and Safety of Bevacizumab-Containing Therapy in Newly Diagnosed Ovarian Cancer: ROSiA Single-Arm Phase 3B Study

Por Oza, Amit M., Selle, Frédéric, Davidenko, Irina, Korach, Jacob, Mendiola, Cesar, Pautier, Patricia, Chmielowska, Ewa, Bamias, Aristotelis, DeCensi, Andrea, Zvirbule, Zanete, González-Martín, Antonio, Hegg, Roberto, Joly, Florence, Zamagni, Claudio, Gadducci, Angiolo, Martin, Nicolas, Robb, Stephen, Colombo, Nicoletta
Publicado no Int J Gynecol Cancer (2017)

FOXO3a loss is a frequent early event in high-grade pelvic serous carcinogenesis

Por Levanon, Keren, Sapoznik, Stav, Bahar-Shany, Keren, Brand, Hadar, Shapira-Frommer, Ronnie, Korach, Jacob, Hirsch, Michelle S., Roh, Michael H., Miron, Alexander, Liu, Joyce F., Vena, Natalie, Ligon, Azra H., Fotheringham, Susan, Bailey, Dyane, Flavin, Richard J., Birrer, Michael J., Drapkin, Ronny I.
Publicado em 2013

Activation-Induced Cytidine Deaminase Links Ovulation-Induced Inflammation and Serous Carcinogenesis

Por Sapoznik, Stav, Bahar-Shany, Keren, Brand, Hadar, Pinto, Yishay, Gabay, Orshay, Glick-Saar, Efrat, Dor, Chen, Zadok, Oranit, Barshack, Iris, Zundelevich, Adi, Gal-Yam, Einav Nili, Yung, Yuval, Hourvitz, Ariel, Korach, Jacob, Beiner, Mario, Jacob, Jasmine, Levanon, Erez Y., Barak, Michal, Aviel-Ronen, Sarit, Levanon, Keren
Publicado no Neoplasia (2016)